The Lymphoid Variant of Hypereosinophilic Syndrome
Guillaume Lefevre
,
Marie-Christine Copin
,
Delphine Staumont-Sallé
,
Martine Avenel-Audran
,
Hélène Aubert
et al.
Journal articles
hal-02083252v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill
,
Catherine Thieblemont
,
Lucie Oberic
,
Anne Moreau
,
Krimo Bouabdallah
et al.
Journal articles
hal-02329536v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial
Salim Kanoun
,
Alina Berriolo-Riedinger
,
Ilan Tal,
,
V Edeline,
,
Anne Ségolène Cottereau
et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , European-Association-of-Nuclear-Medicine (EANM), Oct 2016, Barcelone, Spain. pp.S125-S126 ; Meeting Abstract: OP406
Conference papers
hal-01472426v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?
Pierre Sujobert
,
Gilles Salles
,
Emmanuel Bachy
Journal articles
hal-01800003v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming
Sylvain Carras
,
Dimitri Chartoire
,
Sylvain Mareschal
,
Maël Heiblig
,
Antoine Marçais
et al.
Journal articles
inserm-03280949v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies
Pierre Sujobert
,
Yannick Le Bris
,
Laurence de Leval
,
Audrey Gros
,
Jean Philippe Merlio
et al.
Journal articles
hal-02397399v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
CD1d-restricted peripheral T cell lymphoma in mice and humans
Emmanuel Bachy
,
Mirjam Urb
,
Shilpi Chandra
,
Rémy Robinot
,
Gabriel Bricard
et al.
Journal articles
hal-01305487v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Definition of a minimal genes set for mature lymphoid blood diseases
Pierre Sujobert
,
Yannick Le Bris
,
Laurence de Leval
,
Audrey Gros
,
Jean Philippe Merlio
et al.
Journal articles
hal-01870189v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
Marie-Hélène Delfau-Larue
,
Wolfram Klapper
,
Françoise Berger
,
Fabrice Jardin
,
Josette Brière
et al.
Journal articles
hal-02331700v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Pierre Raynaud
,
Sylvie Caulet-Maugendre
,
Charles Foussard
,
Gilles Salles
,
Anne Moreau
et al.
Journal articles
istex
hal-00678052v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
Sydney Dubois
,
Pierre-Julien Viailly
,
Elodie Bohers
,
Philippe Bertrand
,
Philippe Ruminy
et al.
Journal articles
hal-01526582v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders
Clémentine Sarkozy
,
Sophie Kaltenbach
,
Pierre Faurie
,
Danielle Canioni
,
Françoise Berger
et al.
Journal articles
hal-01795702v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Mutational landscape of gray zone lymphoma
Clémentine Sarkozy
,
Stacy Hung
,
Elizabeth Chavez
,
Gerben Duns
,
Katsuyoshi Takata
et al.
Journal articles
hal-03257279v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
Hervé Tilly
,
Franck Morschhauser
,
Olivier Casasnovas
,
Thierry Jo Molina
,
Pierre Feugier
et al.
Journal articles
hal-02329073v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
Franck Morschhauser
,
Gilles Salles
,
Steven Le Gouill
,
Hervé Tilly
,
Catherine Thieblemont
et al.
Journal articles
hal-01928199v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.
Franck Morschhauser
,
Christian Recher
,
Noël Milpied
,
Remy Gressin
,
Gilles Salles
et al.
Journal articles
inserm-00862711v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Impact of 18F-fluorodeoxyglucose Positron Emission Tomography Response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy : a prospective study from the group d'Etudes des lymphomes de l'adulte and GOELAMS.
Jehan Dupuis
,
Alina Berriolo-Riedinger
,
Anne Julian
,
Pauline Brice
,
Christelle Tychyj
et al.
Journal of Clinical Oncology , 2012, 10 (35), pp.4317-22
Journal articles
hal-00941072v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
Lorric Delage
,
Mireille Lambert
,
Emilie Bardel
,
Cindy Kundlacz
,
Dimitri Chartoire
et al.
Journal articles
hal-03863355v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial
Natacha Heutte
,
Henning Flechtner
,
Nicolas Mounier
,
Wilhelmina Am Mellink
,
Jacobus Meerwaldt
et al.
Journal articles
istex
hal-02359039v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.
Emmanuel Bachy
,
Roch Houot
,
Franck Morschhauser
,
Anne Sonet
,
Pauline Brice
et al.
Journal articles
hal-00933219v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
Sarah Huet
,
Bruno Tesson
,
Jean-Philippe Jais
,
Andrew Feldman
,
Laura Magnano
et al.
Journal articles
hal-01788996v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
Emmanuel Bachy
,
Roch Houot
,
Pierre Feugier
,
Krimo Bouabdallah
,
Reda Bouabdallah
et al.
Journal articles
hal-03679319v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma
Sylvain Mareschal
,
Sydney Dubois
,
Pierre-Julien Viailly
,
Philippe Bertrand
,
Elodie Bohers
et al.
Journal articles
istex
hal-01237083v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study
Sydney Dubois
,
Pierre-Julien Viailly
,
Sylvain Mareschal
,
Elodie Bohers
,
Philippe Bertrand
et al.
Journal articles
hal-01343064v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
Christiane Copie-Bergman
,
Peggy Cuillière-Dartigues
,
Maryse Baia
,
Josette Brière
,
Richard Delarue
et al.
Journal articles
hal-02331572v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Catherine Thieblemont
,
Hervé Tilly
,
Maria Gomes Da Silva
,
Rene-Olivier Casasnovas
,
Christophe Fruchart
et al.
Journal articles
hal-01609346v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association
Clémentine Sarkozy
,
Thierry Molina
,
Hervé Ghesquières
,
Anne-Sophie Michallet
,
Jehan Dupuis
et al.
Journal articles
hal-01471621v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up.
Philippe Colombat
,
Nicole Brousse
,
Gilles Salles
,
Franck Morschhauser
,
Pauline Brice
et al.
Journal articles
inserm-00821113v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study
Franck Morschhauser
,
Steven Le Gouill
,
Pierre Feugier
,
Sarah Bailly
,
Emmanuelle Nicolas-Virelizier
et al.
Journal articles
hal-02586078v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More